Inverse agonist activity of agouti and agouti-related protein.

Biao-Xin Chai,Richard R Neubig,Glenn L Millhauser,Darren A Thompson,Pilgrim J Jackson,Gregory S Barsh,Chris J Dickinson,Ji-Yao Li,Yu-Mei Lai,Ira Gantz
DOI: https://doi.org/10.1016/S0196-9781(03)00104-9
IF: 3.867
2003-01-01
Peptides
Abstract:Agouti and agouti-related protein (AgRP) are endogenous antagonists of the melanocortin receptors (MCxR). Previous data showed that recombinant full-length agouti and a synthetic fragment of AgRP, AgRP (83–132), are inverse agonists at the MC1R and MC4R, respectively. This study demonstrates the smaller analogs AgRP (87–120) and ASIP [90–132 (L89Y)], and short peptides Yc[CRFFNAFC]Y and Qc[CRFFRSAC]S are also MC4R inverse agonists. Furthermore, the relative affinity of the series of MC4R ligands for displacement of radiolabeled antagonist 125I-AgRP (86–132) versus radiolabeled agonist 125I-NDP-MSH did not correlate with ligand efficacy, which is more consistent with an induced-fit model than a simple two-state model of MC4R activation. These data shed new light on the determinants and mechanism of inverse agonism at the MC4R.
What problem does this paper attempt to address?